Get startedLog in
    Picture of SCHOTT Pharma AG & Co KgaA logo

    1SXP — SCHOTT Pharma AG & Co KgaA Balance Sheet

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapFalling Star
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual balance sheet for SCHOTT Pharma AG & Co KgaA, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

    2020
    September 30th
    2021
    September 30th
    2022
    September 30th
    2023
    September 30th
    2024
    September 30th
    Period Length:—————
    Source:ARSARSARSARSARS
    Standards:———
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Cash
    Cash and Equivalents
    Short Term Investments
    Cash and Short Term Investments19.328.230.628.426.9
    Net Total Accounts Receivable
    Net Total Receivables153187385285409
    Total Inventory
    Prepaid Expenses
    Total Other Current Assets
    Total Current Assets239302555468589
    Gross Property, Plant And Equipment
    Accumulated Depreciation
    Net Property, Plant And Equipment267334517638723
    Net Goodwill
    Net Intangible Assets
    Long Term Investments
    Long Term Notes Receivable
    Other Long Term Assets
    Total Assets5967401,1971,2321,442
    Accounts Payable
    Accrued Expenses
    Notes Payable / Short Term Debt
    Current Portion of Long Term Debt / Capital Leases
    Total Other Current Liabilities
    Total Current Liabilities210244323351435
    Long Term Debt
    Capital Lease Obligations
    Total Long Term Debt
    Total Debt
    Deferred Income Tax
    Minority Interest
    Total Other Liabilities
    Total Funded Status
    Total Liabilities281322489541652
    Common Stock
    Additional Paid In Capital
    Retained Earnings (Accumulated Deficit)
    Other Equity
    Total Equity315418707690790
    Total Liabilities & Shareholders' Equity5967401,1971,2321,442
    Total Common Shares Outstanding